US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Levothyroxine Sodium Tablets

Reason Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Alvogen, Inc NDC 47781-654-90 D-0353-2023
Class II · Moderate risk Terminated

Abelcet

Reason Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.

Leadiant Biosciences, Inc. NDC 57665-101-41 D-0327-2023
Class II · Moderate risk Terminated

Posaconazole Delayed-Release Tablets

Reason Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.

Biocon Pharma INC NDC 70377-038-11 D-0268-2023
Class II · Moderate risk Ongoing

Delsam Pharma's ARTIFICIAL TEARS

Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Global Pharma Healthcare Private Limited D-0922-2023
Class II · Moderate risk Ongoing

Artificial Tears

Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0920-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0160-5 D-0345-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0150-5 D-0344-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0145-5 D-0343-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0135-5 D-0342-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0125-5 D-0341-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0120-5 D-0340-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0117-5 D-0339-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0115-5 D-0338-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0113-5 D-0337-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0112-5 D-0336-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0110-5 D-0335-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0155-5 D-0334-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0140-5 D-0333-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0130-5 D-0332-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0105-5 D-0331-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

Amerisource Health Services LLC D-0436-2023
Class II · Moderate risk Terminated

Ohm Sanitizer Spray

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0264-2023
Class II · Moderate risk Terminated

Ohm Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0263-2023
Class II · Moderate risk Ongoing

Hand Sanitizer

Reason CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.

Fisher Scientific Co., LLC D-0164-2023
Class II · Moderate risk Ongoing

Hand Sanitizer

Reason CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.

Fisher Scientific Co., LLC D-0163-2023